Morgan Stanley Maintains Equal-Weight on bluebird bio, Lowers Price Target to $68
Morgan Stanley maintains bluebird bio (NASDAQ:BLUE) with a Equal-Weight and lowers the price target from $73 to $68.
Benzinga · 3天前
Why Bluebird Bio's Stock Is Trading Higher Today
Bluebird Bio (NASDAQ: BLUE) shares are trading higher on Thursday after the company reported second-quarter EPS and sales results up from last year. Wedbush also maintained its Outperform rating on the stock.View more earnings on BLUEBluebird Bio is a clinical
Benzinga · 08/06 15:42
bluebird bio EPS beats by $2.16, beats on revenue
bluebird bio (NASDAQ:BLUE): Q2 GAAP EPS of -$0.36 beats by $2.16. Revenue of $198.89M (+1395.4% Y/Y) beats by $117.82M. Press Release
seekingalpha · 08/06 02:02
Bluebird Bio (BLUE) Reports Q2 Loss, Tops Revenue Estimates
Bluebird (BLUE) delivered earnings and revenue surprises of 81.15% and 95.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/06 00:25
bluebird bio Reports Second Quarter 2020 Financial Results and Recent Operational Progress
bluebird bio, Inc. (NASDAQ: BLUE) today reported financial results and business highlights for the second quarter ended June 30, 2020 and shared recent operational progress.
Business Wire · 08/05 20:10
Why Earnings Season Could Be Great for bluebird bio (BLUE)
bluebird bio (BLUE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zacks · 08/05 12:41
bluebird bio Announces August Investor Event
bluebird bio, Inc. (NASDAQ: BLUE) today announced members of the management team will participate in the Canaccord Genuity 40th Annual Growth Conference, Wednesday, August 12, at 10:30 a.m. ET.
Business Wire · 07/31 12:00
Bluebird Bio (BLUE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Bluebird (BLUE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.